Skip to main content

Find Clinical Trials

Home
Conditions
Intrahepatic Cholangiocarcinoma (Icc)

Clinical trial condition

Intrahepatic Cholangiocarcinoma (Icc)

Explore clinical trials studying Intrahepatic Cholangiocarcinoma (Icc). Study availability and eligibility vary by location and protocol.

33 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Intrahepatic Cholangiocarcinoma (Icc) trial results

Active, Not Recruiting

AI Multimodal Model for Liver Cancer Diagnosis and Prognosis

NCT07658586

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations: Guangxi Medical University First Affiliated Hospital Nanning, Guangxi, China

View Trial Details

Active, Not Recruiting

Efficacy and Safety of HAIC Combined With Lenvatinib and PD-1 Inhibitors for Advanced Intrahepatic Cholangiocarcinoma

NCT07646717

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Active, Not Recruiting

A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors

NCT06777316

Conditions: Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +15 more
Locations: Stanford Cancer Institute Palo Alto, California, United States

Mayo Clinic Jacksonville Jacksonville, Florida, United States

Moffitt Cancer Center Tampa, Florida, United States

University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States

View all 13 locations

View Trial Details